NDATOPICALCREAM
Approved
Jul 2020
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
3/8 — Basic
WYNZORA (calcipotriene and betamethasone dipropionate) by PharmaIN is 3 analog and betamethasone dipropionate as a synthetic corticosteroid. First approved in 2020.
Drug data last refreshed 4h ago · AI intelligence enriched 4h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
WYNZORA is a fixed-dose topical cream combining calcipotriene (vitamin D3 analog) and betamethasone dipropionate (synthetic corticosteroid) for treatment of plaque psoriasis on scalp and body. The combination leverages dual mechanisms—vitamin D analog and corticosteroid activity—though the exact pathways in psoriasis treatment remain incompletely understood. It represents a convenient two-in-one approach to inflammatory skin disease management.
Peak12.5 years to LOE
Product is at peak lifecycle stage with no reported competitive pressure, indicating stable market position and established team infrastructure.
Mechanism of Action
3 analog and betamethasone dipropionate as a synthetic corticosteroid. However, while their pharmacologic and clinical effects are known, the exact mechanisms of their actions in the treatment of plaque psoriasis of the scalp and body are unknown.
Pharmacologic Class:
Vitamin D Analog
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
WYNZORA currently shows zero linked job openings, but as a peak-lifecycle topical agent with strong patent protection and no competitive pressure, roles exist primarily in brand management, field sales, and medical affairs. Career value lies in managing a stable, profitable product with established market presence and long exclusivity runway.
Brand Manager
Worked on WYNZORA at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.